Genus (LON:GNS – Free Report) had its price objective upped by Shore Capital from GBX 2,630 to GBX 2,900 in a research note published on Thursday morning, Marketbeat reports. They currently have a buy rating on the stock.
Separately, Deutsche Bank Aktiengesellschaft upped their target price on Genus from GBX 2,250 to GBX 2,550 and gave the stock a “buy” rating in a report on Tuesday, July 15th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of GBX 2,725.
Get Our Latest Analysis on GNS
Genus Price Performance
About Genus
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Stories
- Five stocks we like better than Genus
- How Can Investors Benefit From After-Hours Trading
- Equal Weight ETFs: Hidden Upside in Today’s Market
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Zillow Group Approaching Key Technical Levels: Is It Time to Buy?
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- For True Diversification: 3 Stocks You Can Buy Now
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.